{"id":"https://openalex.org/W2168399386","doi":"https://doi.org/10.1023/a:1010604502627","title":"Breast Cancer Survival and in Vitro Tumor Response in the Extreme Drug Resistance Assay","display_name":"Breast Cancer Survival and in Vitro Tumor Response in the Extreme Drug Resistance Assay","publication_year":2001,"publication_date":"2001-04-01","ids":{"openalex":"https://openalex.org/W2168399386","doi":"https://doi.org/10.1023/a:1010604502627","mag":"2168399386","pmid":"https://pubmed.ncbi.nlm.nih.gov/11510694"},"language":"en","primary_location":{"id":"doi:10.1023/a:1010604502627","doi":"https://doi.org/10.1023/a:1010604502627","is_oa":false,"landing_page_url":"https://doi.org/10.1023/a:1010604502627","pdf_url":null,"source":{"id":"https://openalex.org/S142211178","display_name":"Breast Cancer Research and Treatment","issn_l":"0167-6806","issn":["0167-6806","1573-7217"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer Research and Treatment","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102855185","display_name":"Rita S. Mehta","orcid":"https://orcid.org/0000-0002-3942-0307","observed_orcids":["https://orcid.org/0000-0002-3942-0307"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rita S. Mehta","raw_affiliation_strings":["Oncotech, Inc., Irvine, CA 92614, USA","Oncotech, Inc., CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncotech, Inc., Irvine, CA 92614, USA","institution_ids":[]},{"raw_affiliation_string":"Oncotech, Inc., CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105776115","display_name":"Richard S. Bornstein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard Bornstein","raw_affiliation_strings":["Center for Breast Health, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Breast Health, OH","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015971951","display_name":"Ing-Ru Yu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ing-Ru Yu","raw_affiliation_strings":["Oncotech, Inc., CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncotech, Inc., CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103364046","display_name":"Ricardo J. Parker","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ricardo J. Parker","raw_affiliation_strings":["Oncotech, Inc., CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncotech, Inc., CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103071787","display_name":"Christine E. McLaren","orcid":"https://orcid.org/0000-0002-7932-9903","observed_orcids":["https://orcid.org/0000-0002-7932-9903"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christine E. McLaren","raw_affiliation_strings":["Chao Family Comprehensive Cancer Research Center, University of California, Irvine, Orange, CA, USA","Epidemiology Division, Department of Medicine, University of California, Irvine, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chao Family Comprehensive Cancer Research Center, University of California, Irvine, Orange, CA, USA","institution_ids":["https://openalex.org/I204250578"]},{"raw_affiliation_string":"Epidemiology Division, Department of Medicine, University of California, Irvine, CA, USA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082212316","display_name":"Khanh P. Nguyen","orcid":"https://orcid.org/0000-0003-3605-3406","observed_orcids":["https://orcid.org/0000-0003-3605-3406"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Khanh P. Nguyen","raw_affiliation_strings":["Chao Family Comprehensive Cancer Research Center, University of California, Irvine, Orange, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chao Family Comprehensive Cancer Research Center, University of California, Irvine, Orange, CA, USA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007011318","display_name":"Kuo-Tung Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kuo-Tung Li","raw_affiliation_strings":["Chao Family Comprehensive Cancer Research Center, University of California, Irvine, Orange, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chao Family Comprehensive Cancer Research Center, University of California, Irvine, Orange, CA, USA","institution_ids":["https://openalex.org/I204250578"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061918246","display_name":"John P. Fruehauf","orcid":"https://orcid.org/0000-0002-9447-9440","observed_orcids":["https://orcid.org/0000-0002-9447-9440"]},"institutions":[{"id":"https://openalex.org/I204250578","display_name":"University of California, Irvine","ror":"https://ror.org/04gyf1771","country_code":"US","type":"education","lineage":["https://openalex.org/I204250578"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John P. Fruehauf","raw_affiliation_strings":["Chao Family Comprehensive Cancer Research Center, University of California, Irvine, Orange, CA, USA","Oncotech, Inc., CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chao Family Comprehensive Cancer Research Center, University of California, Irvine, Orange, CA, USA","institution_ids":["https://openalex.org/I204250578"]},{"raw_affiliation_string":"Oncotech, Inc., CA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4190,"currency":"USD","value_usd":4190},"apc_paid":null,"fwci":1.1346,"has_fulltext":false,"cited_by_count":55,"citation_normalized_percentile":{"value":0.77625459,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"66","issue":"3","first_page":"225","last_page":"237"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9765999913215637,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.006899999920278788,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.006800000090152025,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9589999914169312},{"id":"https://openalex.org/keywords/in-vitro-drug-resistance","display_name":"in vitro drug resistance","score":0.8569999933242798},{"id":"https://openalex.org/keywords/chemotherapy-response","display_name":"chemotherapy response","score":0.6299999952316284},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7480000257492065},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.9449999928474426},{"id":"https://openalex.org/keywords/4-hydroxycyclophosphamide","display_name":"4-hydroxycyclophosphamide","score":0.9480000138282776},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9890000224113464},{"id":"https://openalex.org/keywords/ac-chemotherapy","display_name":"AC chemotherapy","score":0.5889999866485596},{"id":"https://openalex.org/keywords/cmf-chemotherapy","display_name":"CMF chemotherapy","score":0.9929999709129333},{"id":"https://openalex.org/keywords/treatment-selection","display_name":"treatment selection","score":0.5389999747276306},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6840000152587891}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7209998369216919},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7086414098739624},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.647750973701477},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5760962963104248},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5686265826225281},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5052161812782288},{"id":"https://openalex.org/C144301174","wikidata":"https://www.wikidata.org/wiki/Q7893852","display_name":"Univariate analysis","level":3,"score":0.43215441703796387},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42812225222587585},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.33090752363204956},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.1947997510433197},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.15864628553390503},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001681","descriptor_name":"Biological Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1023/a:1010604502627","doi":"https://doi.org/10.1023/a:1010604502627","is_oa":false,"landing_page_url":"https://doi.org/10.1023/a:1010604502627","pdf_url":null,"source":{"id":"https://openalex.org/S142211178","display_name":"Breast Cancer Research and Treatment","issn_l":"0167-6806","issn":["0167-6806","1573-7217"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast Cancer Research and Treatment","raw_type":"journal-article"},{"id":"pmid:11510694","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11510694","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Breast cancer research and treatment","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W166716290","https://openalex.org/W850470413","https://openalex.org/W1262485082","https://openalex.org/W1562190372","https://openalex.org/W1579641819","https://openalex.org/W1602683256","https://openalex.org/W1830444419","https://openalex.org/W1846747462","https://openalex.org/W1884552087","https://openalex.org/W1907604566","https://openalex.org/W1909141355","https://openalex.org/W1939003096","https://openalex.org/W1955744924","https://openalex.org/W1976052438","https://openalex.org/W1999130958","https://openalex.org/W2061032816","https://openalex.org/W2081033831","https://openalex.org/W2115293064","https://openalex.org/W2131321361","https://openalex.org/W2136776823","https://openalex.org/W2157800681","https://openalex.org/W2164789874","https://openalex.org/W2214029008","https://openalex.org/W2407196004","https://openalex.org/W2413853954","https://openalex.org/W2414613535","https://openalex.org/W2597616474","https://openalex.org/W2615106808","https://openalex.org/W4236605185"],"related_works":["https://openalex.org/W2015855320","https://openalex.org/W7099669020","https://openalex.org/W2101616870","https://openalex.org/W2015382854","https://openalex.org/W1992258157","https://openalex.org/W1974476015","https://openalex.org/W1987129195","https://openalex.org/W4249695660","https://openalex.org/W84548433","https://openalex.org/W2139044925"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}